|
|
Volumn 88, Issue 9, 2000, Pages 2042-2046
|
|
High dose inhalation interleukin-2 therapy for lung metastases in patients with malignant melanoma
a
|
|
Author keywords
Inhalation; Interleukin (IL) 2; Malignant melanoma; Pulmonary metastasis; Stage IV
|
|
Indexed keywords
DACARBAZINE;
RECOMBINANT INTERLEUKIN 2;
ADULT;
AGED;
ANOREXIA;
ARTICLE;
CANCER STAGING;
CLINICAL ARTICLE;
COUGHING;
DOSE RESPONSE;
DRUG EFFECT;
FATIGUE;
FEMALE;
FEVER;
HUMAN;
LEUKOPENIA;
LUNG METASTASIS;
MALE;
MELANOMA;
NAUSEA;
PRIORITY JOURNAL;
PSYCHOSIS;
QUALITY OF LIFE;
ADMINISTRATION, INHALATION;
ANTINEOPLASTIC AGENTS;
ANTINEOPLASTIC AGENTS, ALKYLATING;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CAUSE OF DEATH;
CONFOUNDING FACTORS (EPIDEMIOLOGY);
DACARBAZINE;
DISEASE PROGRESSION;
FEMALE;
FOLLOW-UP STUDIES;
HUMANS;
INTERLEUKIN-2;
LUNG NEOPLASMS;
MALE;
MELANOMA;
RECOMBINANT PROTEINS;
REMISSION INDUCTION;
REPRODUCIBILITY OF RESULTS;
SAFETY;
TREATMENT OUTCOME;
|
|
EID: 0034192167
PISSN: 0008543X
EISSN: None
Source Type: Journal
DOI: 10.1002/(SICI)1097-0142(20000501)88:9<2042::AID-CNCR9>3.0.CO;2-J Document Type: Article |
|
Times cited : (36)
|
|
References (5)
|
